For every successful market entry, approximately four fail. That ratio, documented by McKinsey across decades of business history, holds regardless of company size, industry, or geography. It applies to seasoned multinationals and well-capitalized mid-market firms alike.
A Harvard Business Review study of 20,000 companies across 30 countries found that those selling abroad averaged a return on assets of negative one percent for as long as five years after expansion. It took a full decade to reach even modest profitability. Only 40 percent ever exceeded a 3 percent return. Separately, academic research on foreign-controlled businesses in the United States found that more than 70 percent of failures occurred within the first five years of investment.
These are not outlier findings. They are the statistical norm. And the companies producing these results are not unsophisticated. They have strong products, experienced leadership, and real capital to deploy. The problem is not effort. It is not product quality. It is something structural — and it is almost never diagnosed before the money is spent.
The One-Playbook Model
The market entry advisory industry responds to nearly every expansion the same way: produce a market study, provide introductions, recommend a local hire, and move on. The deliverable is a report. The engagement is a project. The client is left to convert research into revenue on their own, in a market they do not fully understand, with no relationships, no field presence, and no system connecting intelligence to execution.
McKinsey’s own analysis of why market entry decisions fail identifies a precise mechanism: cognitive biases lead executives to focus on the case in front of them rather than structural predictors of success — and the advisory process mirrors those biases instead of correcting them. As Harrison and Shirom’s consulting diagnostic framework states plainly: without careful diagnosis, decision-makers waste effort by failing to attack the root cause.
The evidence on government trade programs reinforces this. A University of Twente study of Dutch trade missions found no supported link between mission characteristics and actual contracts signed. A US Government Accountability Office review found that several companies reported their agreements would have occurred without the program’s involvement. Research on Canadian trade missions, once properly controlled, produced effects statistically indistinguishable from zero. These programs generate surface-level contact. They do not resolve the structural constraints that determine whether a company succeeds or fails.
Three Distinct Constraints
International expansion does not fail for one reason. It fails for three — and each one demands a fundamentally different response. Applying the same playbook to all three is precisely why the conventional model underperforms.
Timing
In relationship-driven B2B markets, the decision on who gets the business is made long before the opportunity becomes publicly visible. Forrester’s 2024 research found that 92 percent of buyers begin the purchasing process with a vendor already in mind. Their 2025 data shows the pre-contact front-runner wins 80 percent of the time. Gartner estimates that 83 percent of the buying journey is complete before sustained vendor engagement begins.
For an international company entering the US, the implication is severe. The competition is not other vendors. It is the decision that was made months ago, in a room the company did not know existed. This is not a sales problem. It is an intelligence problem — and no amount of outreach will compensate for arriving after the specification is set.
Access
Some companies know the opportunities exist. They can see the market. They simply cannot get in the room. Cold outreach produces a 2 to 3 percent connect rate. Warm introductions produce 40 to 60 percent — a differential of 15 to 30 times. Referral-based leads convert at 11 percent on average, the highest of any B2B acquisition channel. Cold sources convert at 0.2 to 2 percent.
Corporate Visions research found that 84 percent of B2B buyers ultimately choose a vendor they have worked with before. The structural logic is straightforward: switching vendors means the buyer personally owns the risk of failure. Staying with the incumbent distributes that risk across a historical decision. For a foreign company entering without established US relationships, every conversation requires displacing someone who is already trusted. That is not a visibility problem. It is a relationship architecture problem.
Infrastructure
The product is proven. There may be genuine US demand. But there is no path to market at scale. According to the World Trade Organization, 75 percent of world trade flows through indirect channels — not direct sales. Forrester’s channel research shows that partner-sourced deals are 53 percent more likely to close and close 46 percent faster than direct deals. Seventy-two percent of companies report lower customer acquisition costs through partners than through direct methods.
Closing one deal is not the same as building a commercial presence. Without distribution architecture, channel relationships, or a partnership framework, individual wins remain isolated. The market clears indirectly. A company without infrastructure has no mechanism to participate at scale.
The Diagnostic Principle
Each of these failure modes requires a different type of intelligence and a different type of execution. A timing problem demands early signal detection. An access problem demands relationship engineering. An infrastructure problem demands channel architecture. The one-playbook model cannot distinguish between them. That is its structural limitation.
An RSR Marketing case study illustrates the cost of skipping the diagnostic step: a company entered an engagement believing the barrier was product design. The assessment revealed the actual constraint was channel access and support network architecture. The recommended intervention was the opposite of the company’s hypothesis. Without the diagnostic, they would have invested in the wrong solution entirely.
The first question an international company should ask before committing capital to US expansion is not who can help us. It is what is actually blocking us. The answer to that question determines what the engagement should look like. Most firms never ask it.
